NeuroMetrix Overview

  • Founded
  • 1996
  • Status
  • Public
  • Employees
  • 23
  • Stock Symbol
  • NURO
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $4.38
  • (As of Tuesday Closing)

NeuroMetrix General Information


NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment of being Medical equipment and consumables.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Therapeutic Devices
Other Industries
Diagnostic Equipment
Stock Exchange
Primary Office
  • 4b Gill Street
  • Woburn, MA 01801
  • United States
+1 (781) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroMetrix Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.38 $4.48 $2.70 - $38.75 $31.2M 7.13M 1.57M -$0.56

NeuroMetrix Financials Summary

In Thousands,
TTM 31-Mar-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 7,051 10,971 8,209 2,624
Revenue 8,400 8,253 7,378 9,273
EBITDA (3,113) (2,205) (2,002) (3,649)
Net Income (3,180) (2,281) (2,092) (3,773)
Total Assets 26,248 24,888 7,995 6,894
Total Debt 432 535 1,061 1,505
Public Fundamental Data provided by Morningstar, Inc. disclaimer

NeuroMetrix Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NeuroMetrix‘s full profile, request access.

Request a free trial

NeuroMetrix Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capa
Therapeutic Devices
Woburn, MA
23 As of 2021
000000000 00000

000 0000

smod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exerc
00000000000 0000000
Lewisville, TX
0000 As of 0000
0.000 0000-00-00
000000&0 00000


lum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa q
00000000000 0000000
Mineral Wells, TX
00 As of 0000
000000000 -
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NeuroMetrix Competitors (41)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DJO Global Formerly PE-Backed Lewisville, TX 0000 00000 000000&0 00000
00000-0000 Private Equity-Backed Mineral Wells, TX 00 000000000 -
00000000 0000000 Corporate Backed or Acquired Stockton, CA 000000&0
00000000 Venture Capital-Backed Pompano Beach, FL 000 00000 00000000000 00000
000000000 Formerly PE-Backed Durham, NC 0000 00000 00000000 00000
You’re viewing 5 of 41 competitors. Get the full list »

NeuroMetrix Patents

NeuroMetrix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200179694-A1 Intelligent determination of therapeutic stimulation intensity for transcutaneous electrical nerve stimulation Pending 07-Dec-2018 0000000000
US-20140309709-A1 Transcutaneous electrical nerve stimulator with automatic detection of user sleep-wake state Granted 15-Apr-2013 00000000000 00
US-10279179-B2 Transcutaneous electrical nerve stimulator with automatic detection of user sleep-wake state Active 15-Apr-2013 00000000000 00
US-20200023182-A1 Transcutaneous electrical nerve stimulator with automatic detection of user sleep-wake state Pending 15-Apr-2013 00000000000
US-20180140834-A1 Transcutaneous electrical nerve stimulator with user gesture detector and electrode-skin contact detector, with transient motion detector for increasing the accuracy of the same Granted 29-Mar-2013 A61N1/36021
To view NeuroMetrix’s complete patent history, request access »

NeuroMetrix Executive Team (6)

Name Title Board Seat Contact Info
Shai Gozani MD Chief Executive Officer & Chairman
Thomas Higgins Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
You’re viewing 2 of 6 executive team members. Get the full list »

NeuroMetrix Board Members (4)

Name Representing Role Since
00000 0000000 00 NeuroMetrix Board Member 000 0000
00000 000 000000000 NeuroMetrix Board Member 000 0000
00000 0000 Self Board Member 000 0000
0000 000000 00 NeuroMetrix Chief Executive Officer & Chairman 000 0000
To view NeuroMetrix’s complete board members history, request access »

NeuroMetrix Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NeuroMetrix Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 0000 0 01-Jan-2009 0000000000 00000 Biotechnology 0000 0000
Eyetel Imaging 26-Dec-2007 Merger/Acquisition 00000 Diagnostic Equipment
To view NeuroMetrix’s complete acquisitions history, request access »